Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Contraception

RSS  

Articles

  • Endometriosis is the focus of new scientific research

    Research has just provided a first step toward providing a more informed way of classifying endometriosis based on the underlying biological cause of the disease. Scientists might be able to develop a patient stratification system similar to that used for breast cancer patients, whose treatments are tailored to the molecular profile of their tumors.
  • New treatment eyed for pain of vulvodynia

    Results of a new study indicate that vulvodynia incidence varies by age, ethnicity, and marital status, with a potential higher risk for women with pre-existing depression, sleep, or pain disorders.
  • CTU Update

  • Use guidance to cut stroke risks in women

    National guidelines have just been developed for preventing stroke in women. Stroke awareness is important, as one in five women will have a stroke in her lifetime. Stroke is the number three cause of death in women; about 55,000 more women than men die of stroke each year.
  • Research stirs debate on mammography

    Results of a new study indicate that annual mammography in women ages 40-59 does not reduce mortality from breast cancer beyond that of physical examination or usual care when adjuvant therapy for breast cancer is freely available.
  • Intrauterine contraception safe and effective in teens and adults

    Results from a recent retrospective analysis indicate that similar to adults, intrauterine device (IUD) use in adolescents and nulliparous women is effective and associated with low rates of serious complications.
  • Generic EC — One step closer to OTC status

    The Food and Drug Administration is looking to generic versions of the levonorgestrel-based emergency contraception (EC) pill Plan B One-Step to submit applications for new labeling after the agency ruled the generic version can be sold on store shelves without restriction.
  • Teratogenic drug use: Check contraception

    About 1.7 million women of childbearing age are prescribed Food and Drug Administration Category D or Category X medications each year. However, despite label warnings, about 6% of U.S. pregnancies occur in women taking medications with known teratogenic risk.
  • Quick Start: Why put off what you can do today?

    For the last 15 years, emerging evidence has encouraged clinicians who prescribe hormonal contraception to quick start patients on their chosen contraceptive method on the day of the visit, instead of waiting until after menses begins.
  • Check digital trends in STI prevention

    The Internet and the cell phone are helping patients in not only seeking testing for sexually transmitted infections (STIs), but learning their test results and promoting treatment for themselves and their partners.